Flyer

Molecular Enzymology and Drug Targets

  • Journal h-index: 5
  • Journal CiteScore: 0.46
  • Journal Impact Factor: 0.45
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • China National Knowledge Infrastructure (CNKI)
  • Publons
  • Google Scholar
  • Secret Search Engine Labs
  • Zenodo
Share This Page

Anshika Panday

Departament of Enzymology, University of New Haven, United States

Publications
  • Editorial   
    Exploring Drug Targets: Advances in Identification and Validation for Therapeutic Development
    Author(s): Anshika Panday*

    Identifying and validating suitable drug targets are a critical step in the process of therapeutic development. This abstract discusses the advances in the field of exploring drug targets, focusing on the identification and validation strategies that have revolutionized the discovery of novel therapeutic targets. The abstract begins by highlighting the importance of identifying and targeting specific molecules or pathways that play a crucial role in disease progression. Traditional drug discovery approaches often relied on serendipitous discoveries or targeting well-known protein families. However, recent advancements in molecular biology, genomics, and bioinformatics have enabled more systematic and targeted approaches for identifying potential drug targets. The abstract discusses the application of high-throughput screening techniques, such as chemical libraries, RNA interference (R.. View More»

    Abstract HTML PDF